ASCO 2020: PROSPER Update Shows Overall Survival Benefit of Enzalutamide in Nonmetastatic Castration-Resistant Prostate Cancer
No new safety concerns were uncovered
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.